Alpha-Terpineol

Alpha-Terpineol

SCHEMBL980991

CC1=CC[C@@H](C(C)(C)O)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 1.00
CES2 O00748 3/20 0.59
CYP3A4 P08684 2/20 0.55
ALOX15 P16050 2/20 0.55
STAT3 P40763 2/20 0.55
MEN1 O00255 1/20 0.55
MAPK1 P28482 1/20 0.55
KMT2A Q03164 1/20 0.55
CHRNA7 P36544 1/20 0.55
PTPN1 P18031 1/20 0.44
TAS2R46 P59540 4/20 0.33
TAS2R31 P59538 2/20 0.33
TAS2R10 Q9NYW0 2/20 0.33
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alpha-Terpineol SCHEMBL10925321 1.00 LMNA (1.00) LMNACES2CYP3A4ALOX15STAT3
Alpha-Terpineol SCHEMBL891812 1.00 LMNA (1.00) LMNACES2CYP3A4ALOX15STAT3
Alpha-Terpineol SCHEMBL28466 1.00 LMNA (1.00) LMNACES2CYP3A4ALOX15STAT3
Alpha-Terpineol SCHEMBL901351 1.00 LMNA (1.00) LMNACES2CYP3A4ALOX15STAT3
Alpha-Terpineol SCHEMBL9562893 0.98 LMNA (0.96) LMNACES2CYP3A4ALOX15STAT3
Nephthenol SCHEMBL14828377 0.93 LMNA (0.86) LMNACES2CYP3A4ALOX15STAT3
Alpha-Terpineol SCHEMBL9706032 0.93 LMNA (0.86) LMNACES2CYP3A4ALOX15STAT3
Alpha-Terpineol SCHEMBL11682479 0.89 LMNA (0.80) LMNACES2CYP3A4ALOX15STAT3
Alpha-Terpineol SCHEMBL8146925 0.85 LMNA (0.73) LMNACES2CYP3A4ALOX15STAT3
SCHEMBL5708608 0.83 LMNA (0.71) LMNACES2CYP3A4ALOX15STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1091 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260114485-A1 METHOD FOR PRODUCING AN ALTERNATIVE CITRUS COMPOSITION AND COMPOSITION THEREOF LIN JIAYOU (US) 2026-04-30 US claimed
WO-2026089741-A1 A METHOD FOR PRODUCING AN ALTERNATIVE CITRUS COMPOSITION AND COMPOSITION THEREOF LIN JIAYOU (US) 2026-04-30 WO claimed
EP-4727657-A1 COSMETIC PREPARATION CONTAINING XANTHAN GUM, TERPINENES AND TERPINEOL Beiersdorf AG (DE) 2026-04-22 EP claimed
US-20260090510-A1 USE OF RESIN ACIDS AS DEFENSE GENE INDUCERS FOR BIOTIC STRESS IN PLANTS ACTION PIN (FR) 2026-04-02 US claimed
US-20260096240-A1 SYSTEMS AND METHOD FOR MANUFACTURING SOLAR CELL PASTE APPLIED CAVITATION INC (US) 2026-04-02 US claimed
EP-4709355-A1 CANNABINOID-BASED FORMULATION MRX Medical Limited (GB) 2026-03-18 EP claimed
US-20260033489-A1 NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS LOPEZ MACIAS JAVIER EDUARDO (MX) 2026-02-05 US claimed
EP-4680421-A1 COMPOSITION FOR FORMING A COPPER-CONTAINING INTERLAYER COMPRISING INTERNAL PORES CuNex GmbH (DE) 2026-01-21 EP claimed
US-12478063-B2 Nanosystems based on nanocomposites and natural extracts LÓPEZ MACÍAS, Javier Eduardo (MX) 2025-11-25 US claimed
EP-4633370-A1 CO-FORMULATION COMPOSITION ACTION PIN (FR) 2025-10-22 EP claimed
US-20220059711-A1 SYSTEMS AND METHOD FOR MANUFACTURING SOLAR CELL PASTE APPLIED CAVITATION, INC. (US) 2022-02-24 US claimed
EP-3949746-A1 TEA AROMATIZING COMPOSITION HAVING FLORAL AROMA Suntory Holdings Limited (JP) 2022-02-09 EP claimed
WO-2021065718-A1 SOLID COMPOSITION CONTAINING LINALOOL, GERANIOL, AND DEXTRIN サントリーホールディングス株式会社 2021-04-08 WO claimed
WO-2008083718-A1 BEVERAGE KIT AND METHOD FOR PRODUCING A NON-FERMENTED MALT BEVERAGE FAYROUZ INTERNATIONAL AG (CH) 2008-07-17 WO claimed
US-20040247669-A1 Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth BENNES, INC. 2004-12-09 US claimed
US-20040151771-A1 Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth BENNES, INC. 2004-08-05 US claimed
WO-2001079212-A1 SILICON DERIVATIVES OF FRAGRANT, FLAVOURING AND MEDICINAL SUBSTANCES KIREEV VYACHESLAV VASILIEVICH (RU) 2001-10-25 WO claimed
EP-0287342-B1 A SUSTAINED RELEASE AROMATIC AND A PROCESS FOR MANUFACTURING THEREOF Kurita Water Industries Ltd. (JP) 1992-10-28 EP claimed
US-4880774-A Sustained release aromatic KURITA WATER INDUSTRIES, LTD. (JP) 1989-11-14 US claimed
EP-0287342-A2 A sustained release aromatic and a process for manufacturing thereof Kurita Water Industries Ltd. (JP) 1988-10-19 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260090510-A1 USE OF RESIN ACIDS AS DEFENSE GENE INDUCERS FOR BIOTIC STRESS IN PLANTS CD68, GRIA3, GRIA1 LMNA 4111/4885CES2 611/4885CYP3A4 3543/4885
US-20260096240-A1 SYSTEMS AND METHOD FOR MANUFACTURING SOLAR CELL PASTE APP, CTNND1, BACE1 LMNA 116/4885CES2 2455/4885CYP3A4 1842/4885
US-20260033489-A1 NANOSYSTEMS BASED ON NANOCOMPOSITES AND NATURAL EXTRACTS SOD3, RPS3, CD63 LMNA 1701/4885CES2 1823/4885CYP3A4 411/4885
US-20260114485-A1 METHOD FOR PRODUCING AN ALTERNATIVE CITRUS COMPOSITION AND COMPOSITION THEREOF NOTUM, PNLIP, ELOVL3 LMNA 830/4885CES2 152/4885CYP3A4 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.